Market Cap: $548.21M
PI
Puma Biotechnology, Inc.
PBYI
NASDAQ (NASDAQ Global Select)USD
Market Cap: $548.21M
Navigating Challenges in Retail: Dick's Sporting Goods' Strategic Pivot After Foot Locker Acquisition In the current retail landscape, Dick's Sporting Goods faces notable challenges following its acqu…
Puma Biotechnology Faces Regulatory Scrutiny Amid Industry Consolidation Puma Biotechnology, a company focused on the commercialization and development of innovative cancer therapies, operates within…
Adidas Faces Revenue Concerns Amid Shift in Market Dynamics Adidas experiences significant challenges as it announces a disappointing revenue outlook for 2026, projecting only high single-digit growth…
Adidas Faces Growth Challenges Amid Market Turbulence, Impacting Industry Peers Adidas experiences significant turbulence as it reveals a disappointing revenue outlook for 2026, forecasting high singl…
Puma Biotechnology Reveals Mixed Earnings Performance Amidst Global Market Caution Puma Biotechnology, a biopharmaceutical company focused on cancer treatment, releases its earnings amidst a backdrop…
### Puma Biotechnology's Role in Shaping Cancer Treatment Innovations Puma Biotechnology stands at the forefront of cancer therapeutics, focusing on the development and commercialization of innovative…
Puma Biotechnology: Innovative Strategies Amidst Competitive Landscape Puma Biotechnology, a leader in the biopharmaceutical industry, continues to make strides in developing innovative cancer therapi…
Puma Biotechnology's Strategic Positioning in the Biopharmaceutical Landscape Puma Biotechnology continues to navigate the complex landscape of the biopharmaceutical industry, particularly focusing on…
Puma Biotechnology: Focusing on Innovative Oncology Solutions Amid Market Buzz Puma Biotechnology remains at the forefront of the oncology sector, continuously advancing its mission to develop and com…
Rising Incidence of Invasive Lobular Carcinoma: Implications for Breast Cancer Research and Treatment A recent study published in the journal Cancer highlights a troubling increase in the incidence of…
Puma Biotechnology Advances Cancer Care with Innovative Trials and Treatments Puma Biotechnology, a prominent player in the biopharmaceutical sector, is making significant strides in cancer treatment…
Puma Biotechnology Enhances Workforce with New Stock Awards Puma Biotechnology, Inc. continues to strengthen its position in the biopharmaceutical sector with a strategic move to attract talent throug…
Puma Biotechnology Strengthens Talent Pool with Inducement Stock Awards Puma Biotechnology, Inc., a prominent player in the biopharmaceutical industry, makes a strategic move to enhance its workforce…
Puma Biotechnology Expands Employee Incentives Amid Growing Oncology Portfolio Puma Biotechnology, Inc. solidifies its commitment to talent retention and motivation with the recent approval of inducem…
Puma Biotechnology's Neratinib Gains Recognition in Cervical Cancer Guidelines Puma Biotechnology, Inc. makes a significant stride in oncology with the recent update from the National Comprehensive Ca…
Puma Biotechnology Strengthens Workforce with Inducement Award for New Talent Puma Biotechnology, Inc. recently announces the approval of an inducement restricted stock unit award for a new non-execut…
Puma Biotechnology Reinforces Commitment to Innovation with New Inducement Award Puma Biotechnology, Inc., a biopharmaceutical company dedicated to advancing cancer care, announces a significant step…
Puma Biotechnology Expands Talent with New Stock Incentive Plan Puma Biotechnology, Inc., a biopharmaceutical company specializing in cancer therapies, makes a significant move to enhance its workforc…